Maryland, 7 Feb 2025: The US Food and Drug Administration (FDA) has warned an active pharmaceutical ingredient (API) maker in India for falsifying manufacturing records and issued a warning letter to a contract testing lab in China for its lax testing approach.
 
O......
View Details

Related News

• Karnataka notifies NDPS Rules, Essential Narcotic Drugs to be regulated under Central Rules (22-03-2025)

---

• One hundred teams participated in 'Operation Garuda', uncovering nearly 40 different types of drugs being sold without prescriptions (22-03-2025)

---

• List of OTC drugs to be Submitted to Govt Soon: Panel Chief (21-03-2025)

---

• DCA seized four medicines for misleading 'Leucoderma', 'Tuberculosis' and 'Fever' treatment claims (21-03-2025)

---

• Skin specialists flag widespread quackery in Kerala (21-03-2025)

---

• SHRC orders criminal proceedings against fake doctor (21-03-2025)

---

• Gujarat HC stays GST action against Gujarat Medical Council, other boards (21-03-2025)

---

• CEPI and AstraZeneca to advance discovery into novel antibody (21-03-2025)

---

• FIR against 3 animal husbandry dept officials booked for sending damaged vaccine to Hospitals (21-03-2025)

---

• Eli Lilly launches blockbuster anti-obesity drug Mounjaro in India (20-03-2025)

---